 Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26
Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores 
              Radhika Rao, Economist, Group Research, DBS Bank:
Tuesday's policy was along expected lines on the rates front, but carried a bigger emphasis on liquidity conditions. Along expected lines, the RBI cut the benchmark rate by 25bps to 6.5% on Tuesday, with an accommodative bias contingent on monsoon progress, direction of headline / core CPI inflation and transmission process.
It was a prudent move to defer a bunched up move, especially in light of the uncertainty that surrounds the impact and extent of the pay commission changes. To recap, the impact of higher public sector wages and housing allowance adjustments are not yet factored into the central bank's inflation estimates.
Meanwhile, today's decision was more focused on addressing liquidity shortage and easing the transmission mechanism. There is a significant shift in their emphasis on the NDTL framework, narrowing the corridor around the operational repo rate and CRR changes. This is to ensure that the easy policy stance percolates to the real economy and materially lowers financing costs. These changes are likely to provide positive impetus to the financial markets in the near-term.